The Fleming Fund Phase I: A Summary - Accessible Version


An accessible version of the Fleming Fund's Phase I Report is available here.

The Phase I Report, titled 'The Fleming Fund Phase I: A Summary', showcases the achievements from the first phase of the programme. It also highlights some of the challenges faced when working in global AMR surveillance, and potential solutions to these problems.

The accessible version of the Phase I Report, available below, is compliant with the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018. For more information, please click here.

We welcome you to share the accessible version of our Phase I Report with interested colleagues and networks. Once you have read it, we would be grateful if you could complete our feedback survey to help the Fleming Fund improve future publications.


The full document is available here

View docx (140.96 KB)

More Like This

To mark One Health Day, we revisit the holistic concept spanning human, animal, and environmental health, which is one of the Fleming Fund’s guiding principles.

A plaque on the side of the Saint Mary’s Hospital in Paddington, London, UK, commemorates the discovery of penicillin, the first antibiotic, in 1928. Fungal spores, blown by the wind, landed on Sir Alexander Fleming's Petri dishes killing the bacteria he was growing leading to a revolution in medicine.